✦ LIBER ✦

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

✍ Scribed by Alice B. Gottlieb; Salman Masuda; Rallapalli Ramamurthi; Ahsan Abdulghani; Pat Romano; Umesh Chaudhari; Lisa T. Dooley; Adedigbo A. Fasanmade; Carrie L. Wagner

Book ID: 117845581
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 255 KB
Volume: 48
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2003.10

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and histologic response to sing

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody

✍ Alice B. Gottlieb; Mark Lebwohl; Mark C. Totoritis; Ahsan A. Abdulghani; Steve R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Unexpected dramatic clinical response of

Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (tnfalpha) monoclonal antibody for Crohn’s Disease

✍ Leslie Bank∗; Belinda Hunt 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra